Sentinel-Node Biopsy or Nodal Observation in Melanoma

20061,820 citationsJournal Articlebronze Open Access

Authors

Donald L. Morton · Saint John's Health Center

John F. Thompson · Royal Prince Alfred Hospital

Alistair J. Cochran · University of California, Los Angeles

Nicola Mozzillo

Robert M. Elashoff · University of California, Los Angeles

Richard Essner · Saint John's Health Center

Omgo E. Nieweg · The Netherlands Cancer Institute

Abstract

The staging of intermediate-thickness (1.2 to 3.5 mm) primary melanomas according to the results of sentinel-node biopsy provides important prognostic information and identifies patients with nodal metastases whose survival can be prolonged by immediate lymphadenectomy. (ClinicalTrials.gov number, NCT00275496 [ClinicalTrials.gov].).

Topics & Keywords

Cutaneous Melanoma Detection and Management Allergic Rhinitis and Sensitization Advanced Biosensing Techniques and Applications

Publication Details

Published in: New England Journal of Medicine

Volume 355, Issue 13, pp. 1307-1317

DOI: 10.1056/nejmoa060992

Field-Weighted Citation Impact: 63.32

Command Palette

Sentinel-Node Biopsy or Nodal Observation in Melanoma

Authors

Abstract

Topics & Keywords

Publication Details